3 Hos alle patienter, der behandles med abacavir, skal den kliniske mistanke om overfølsomhed danne grundlag for beslutning om behandlingen.
3 In any patient treated with abacavir, the clinical diagnosis of suspected hypersensitivity reaction must remain the basis of clinical decision-making.